RNA5SP364

Across TCGA pan-cancer cohorts, RNA5SP364 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RNA5SP364’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where RNA5SP364 RNA is repressed in tumor relative to normal tissue. In most cancer types RNA5SP364 is over-expressed in tumor, although a few such as PAAD show the opposite, repressed pattern.

PAAD, LUSC, and LUAD are the cancer types where RNA5SP364 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNA5SP364 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PAAD	Female	All	−0.925	.033	4	view →
LUSC	Male	All	+0.335	.002	4	view →
LUAD	All	All	+0.316	.002	4	view →
KIRC	All	All	+0.239	.003	4	view →
BRCA	All	All	+0.180	.016	2	view →
LIHC	All	All	+0.061	.022	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

RNA5SP364–PAAD

Open the PAAD breakdown →